Article contents
An open letter to the Executive Editor of the British National Formulary
Published online by Cambridge University Press: 02 January 2018
Extract
Ann Barker
In the preface to the BNF you state that “comments and constructive criticism will be welcome”. I should like to ask a question. I should like to know how members of the Committee reach a decision on what dose should be considered the upper limit of medication, and in particular psychotropic medication, commonly known as “the BNF maximum”.
- Type
- Briefings
- Information
- Creative Commons
- This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
- Copyright
- Copyright © Royal College of Psychiatrists 1993
- 5
- Cited by
eLetters
No eLetters have been published for this article.